PLATELET MEMBRANE FLUIDITY IN TYPE-IIA, TYPE-IIB AND TYPE-IV HYPERLIPOPROTEINEMIA

被引:15
|
作者
MALLE, E
SATTLER, W
PRENNER, E
LEIS, HJ
KARADI, I
KNIPPING, G
ROMICS, L
KOSTNER, GM
机构
[1] GRAZ UNIV,INST BIOCHEM & FOOD CHEM,A-8010 GRAZ,AUSTRIA
[2] GRAZ UNIV,INST PEDIAT,DEPT MASS SPECTROMETRY,A-8010 GRAZ,AUSTRIA
[3] GRAZ TECH UNIV,A-8010 GRAZ,AUSTRIA
[4] SEMMELWEIS UNIV MED,DEPT MED 3,BUDAPEST,HUNGARY
基金
奥地利科学基金会;
关键词
HYPERLIPOPROTEINEMIA; TYPE-IIA; TYPE-IIB; TYPE-IV; MEMBRANE FLUIDITY; PLATELETS;
D O I
10.1016/0021-9150(91)90018-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fluorescence spectroscopy, a very sensitive index for measuring the biophysical properties of living cell systems, was used to examine the structural order of intact, resting, gel-filtered platelets from hyperlipidemic subjects (n = 48, 25-70 years) and normolipemic subjects (n = 34, 19-68 years). Fluorescence anisotropy (r[s]), which is inversely related to membrane fluidity, was estimated using 3 different fluorescent dyes, DPH, TMA-DPH, and 6-AS, known to label different regions of biological membranes. Increased membrane fluidity was observed in type IIB (n = 24, 36-62 yrs; r[s] = 0.0692 +/- 0.09) and type IV (n = 10, 33-57 yrs; r[s] = 0.058 +/- 0.006) hyperlipidemics in comparison to type IIA (n = 14, 25-70 yrs; r[s] = 0.086 +/- 0.019) and control subjects (n = 24, 28-68 yrs; r[s] = 0.079 +/- 0.012). The temperature dependency of r[s]-DPH values was significantly different (P < 0.01) in platelets from type IIB and type IV patients compared to type IIA and control subjects of similar age. A significant positive correlation (P < 0.005) between membrane fluidity and age was found only in healthy control subjects (n = 34, 19-68 yrs). Despite significant (P < 0.01) differences in plasma lipid concentrations in hyperlipidemic patients and controls, significant ex vivo relations between membrane fluidity and lipoprotein concentrations, free fatty acid distribution, and increased age were found only in healthy control subjects. Plasma levels of thromboxane as well as serum selenium concentrations did not significantly differ between hypercholesterolemic, hypertriglyceridemic, and control subjects.
引用
收藏
页码:159 / 167
页数:9
相关论文
共 50 条
  • [1] INCREASED LIPID FLUIDITY OF ERYTHROCYTE-MEMBRANE AND PLATELET IN TYPE-IIB AND TYPE-IV HYPERLIPOPROTEINEMIA
    MULLER, S
    DONNER, M
    DROESCH, S
    DROUIN, P
    STOLTZ, JF
    [J]. CLINICAL HEMORHEOLOGY, 1987, 7 (03): : 442 - 442
  • [2] CELL-MEDIATED IMMUNE-RESPONSE IN PATIENTS WITH TYPE-IIA, TYPE-IIB AND TYPE-IV PRIMARY HYPERLIPOPROTEINEMIA
    ANTONACI, S
    JIRILLO, E
    GAROFALO, AR
    POLIGNANO, A
    RESTA, F
    PUGLIESE, P
    CAPURSO, A
    BONOMO, L
    [J]. CYTOBIOS, 1988, 54 (218-19) : 181 - 189
  • [3] HYPERLIPOPROTEINEMIA TYPE-IIA, TYPE-IIB AND TYPE-IV - EFFICACY OF BEZAFIBRATE RETARD ON LIPIDS, LIPOPROTEINS, AND LP(A) THERAPEUTIC NEWS
    SCHWARTZKOPFF, W
    BIMMERMANN, A
    [J]. MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1988, 130 (22): : 422 - 426
  • [4] ALTERED PLATELET DEFORMABILITY IN PATIENTS WITH TYPE-IIA AND TYPE-IV HYPERLIPOPROTEINEMIA
    SMITH, CM
    BURRIS, SM
    HUNNINGHAKE, DB
    WHITE, JG
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 1988, 27 (04) : 247 - 252
  • [5] PIRIFIBRATE IN THE TREATMENT OF HYPERLIPOPROTEINEMIA - TYPES-IIA, TYPE-IIB, AND TYPE-IV
    RODRIGUEZ, JL
    MARTORELL, J
    [J]. CLINICAL THERAPEUTICS, 1980, 3 (04) : 234 - 241
  • [6] QUANTITATIVE-ANALYSIS OF LIPOPROTEINS IN HYPERLIPOPROTEINEMIAS OF TYPE-IIA, TYPE-IIB AND TYPE-IV
    LOEPER, J
    GOYLOEPER, J
    ROUFFY, J
    [J]. CLINICA CHIMICA ACTA, 1979, 98 (1-2) : 19 - 26
  • [7] PLATELET HALF-LIFE IN PATIENTS WITH PRIMARY HYPERLIPOPROTEINEMIA TYPE-IIA, TYPE-IIB, AND TYPE-IV ACCORDING TO FREDRICKSON WITH AND WITHOUT CLINICAL SIGNS OF ATHEROSCLEROSIS
    JAGER, E
    SINZINGER, H
    WIDHALM, K
    KALIMAN, J
    HOFER, R
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 1982, 94 (16) : 421 - 425
  • [8] THERAPEUTIC EFFECTS OF BEZAFIBRATE AND GEMFIBROZIL IN HYPERLIPOPROTEINEMIA TYPE-IIA AND TYPE-IIB
    KREMER, P
    MAROWSKI, C
    JONES, C
    ACACIA, E
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 1989, 11 (05) : 293 - 303
  • [9] LONG-TERM TREATMENT OF HYPERLIPOPROTEINEMIA, TYPE-IIA AND TYPE-IIB WITH ETIROXATE
    SCHWARTZKOPFF, W
    RUSS, E
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1975, 100 (15) : 815 - 821
  • [10] COMPARATIVE-STUDY OF CLOFIBRATE AND BEZAFIBRATE IN HYPERLIPOPROTEINEMIA TYPE-IIA AND TYPE-IIB
    ARNTZ, HR
    KLEMENS, UH
    LANG, PD
    VOLLMAR, J
    [J]. MEDIZINISCHE KLINIK, 1978, 73 (49): : 1731 - 1737